Literature DB >> 20514280

Montelukast protects against testes ischemia/reperfusion injury in rats.

Hulya Ozturk1, Hayrettin Ozturk, Kaan Gideroglu, Hakan Terzi, Guler Bugdayci.   

Abstract

INTRODUCTION: In this study, we investigate the effect of montelukast on histologic damage induced by testicular torsion-detorsion in rats.
METHODS: Twenty-one male Sprague-Dawley rats were separated into 3 groups, each containing 7 rats. A sham operation was performed in group 1 (control). In group 2 (ischemia-reperfusion [IR]/untreated), 1-hour detorsion of the testis was performed after 6 hours of unilateral testicular torsion. In group 3 (I-R/dextroamphetamine), after performing the same surgical procedures as in group 2, montelukast was given intraperitoneally. In all experimental rats, ipsilateral orchiectomies were performed for histological examination and tissue malondialdehyde (MDA), glutathione and myeloperoxidase assays.
RESULTS: Montelukast treatment significantly decreased the I-R-induced elevation in testes tissue MDA and glutathione levels were found to be preserved. The level of myeloperoxidase (MPO) activity was significantly increased in the testes tissue of the IR/untreated group. However, in I-R/montelukast treatment group significantly decreased testes tissue MPO level. Histopathologically, the in the group 2 rats, edema, congestion, hemorrhage between seminiferous tubules and necrosis of the germinal cells were predominant features in sections. However, most of the specimens in the montelukast treated group 3 showed grades-I and II injury. Additionally, the testicular injury score was lower in group 3 rats compared with group 2.
CONCLUSION: The current findings demonstrate that the montelukast decreased the severity of testicular injury by reversing the oxidative effects of testes I-R.

Entities:  

Year:  2010        PMID: 20514280      PMCID: PMC2874591          DOI: 10.5489/cuaj.09072

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  31 in total

1.  Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization.

Authors:  J Milei; R Ferreira; S Llesuy; P Forcada; J Covarrubias; A Boveris
Journal:  Am Heart J       Date:  1992-02       Impact factor: 4.749

Review 2.  Pathophysiology of ischaemia-reperfusion injury.

Authors:  D L Carden; D N Granger
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

3.  Histological changes occurring in the contralateral testes of prepubertal rats subjected to various durations of unilateral spermatic cord torsion.

Authors:  M J Cosentino; M Nishida; R Rabinowitz; A T Cockett
Journal:  J Urol       Date:  1985-05       Impact factor: 7.450

4.  Peptide and nonpeptide reactive oxygen scavengers provide partial rescue of the testis after torsion.

Authors:  Jeffrey J Lysiak; Quoc An T Nguyen; Terry T Turner
Journal:  J Androl       Date:  2002 May-Jun

5.  Microsomal lipid peroxidation.

Authors:  J A Buege; S D Aust
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

6.  Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.

Authors:  R Holma; P Salmenperä; A Riutta; I Virtanen; R Korpela; H Vapaatalo
Journal:  Eur J Pharmacol       Date:  2001-10-19       Impact factor: 4.432

7.  Inhibition of poly(adenosine diphosphate-ribose) polymerase decreases long-term histologic damage in testicular ischemia-reperfusion injury.

Authors:  Murat Bozlu; Banu Coşkun; Selahittin Cayan; Deniz Acar; Savaş Aktaş; Ercüment Ulusoy; Erdem Akbay
Journal:  Urology       Date:  2004-04       Impact factor: 2.649

Review 8.  Spermatic cord torsion, reactive oxygen and nitrogen species and ischemia-reperfusion injury.

Authors:  Danilo Wilhelm Filho; Moacir A Torres; André L B Bordin; Tânia B Crezcynski-Pasa; Alberto Boveris
Journal:  Mol Aspects Med       Date:  2004 Feb-Apr

Review 9.  Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection.

Authors:  D Ross
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

10.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

Authors:  P P Bradley; D A Priebat; R D Christensen; G Rothstein
Journal:  J Invest Dermatol       Date:  1982-03       Impact factor: 8.551

View more
  6 in total

Review 1.  The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.

Authors:  Malvina Hoxha; G Enrico Rovati; Aurora Bueno Cavanillas
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953

2.  Montelukast prevents testes against ischemia-reperfusion injury through suppression of iNOS expression.

Authors:  Mesrur Selçuk Sılay; Hale Toklu; Ayşim Özağarı; Mustafa Aydın; Şermin Tetik; Göksel Şener; Cengiz Miroğlu; Muammer Kendirci
Journal:  Turk J Urol       Date:  2014-12

3.  Critique and recommendations for an experimental study.

Authors:  Seyda Nur Dagli
Journal:  Hepatol Forum       Date:  2022-04-26

4.  Beneficial effects of montelukast against methotrexate-induced liver toxicity: a biochemical and histological study.

Authors:  Evren Kose; Hilal Irmak Sapmaz; Ediz Sarihan; Nigar Vardi; Yusuf Turkoz; Nihat Ekinci
Journal:  ScientificWorldJournal       Date:  2012-04-01

5.  Effect of etoricoxib on experimental oxidative testicular ischemia-reperfusion damage in rats induced with torsion-detorsion.

Authors:  Turgut Yapanoglu; Fatih Ozkaya; Ali Haydar Yilmaz; Renad Mammadov; Ferda Keskin Cimen; Erkan Hirik; Durdu Altuner
Journal:  Korean J Physiol Pharmacol       Date:  2017-08-22       Impact factor: 2.016

6.  Montelukast for Medical Delay in Flap Surgery.

Authors:  Maryam Iranpour; Ali Khodarahmi; Nima Khodarahmi; Mohammad Shafiee; Reza Malekpourafshar; Nozar Nakhaee
Journal:  World J Plast Surg       Date:  2020-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.